Ifosfamide-based chemotherapy regimens in treatment of lymphoma: the M.D. Anderson experience.

Ifosfamide-based chemotherapy regimens in treatment of lymphoma: the M.D. Anderson experience. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Ifosfamide-based chemotherapy regimens in treatment of lymphoma: the M.D. Anderson experience. Abstract Text:

Investigators at M.D. Anderson Cancer Center in Houston first began investigations with the drug ifosfamide in the early 1970s. This alkylating agent has proven to be a valuable drug with easily manageable side effects in therapy of lymphomas. They have described prognostic factors for relapsed lymphomas using this drug in various combinations and have found it of major value in both cytoreduction and stem cell mobilization prior to transplant. The drug has subsequently become part of many established regimens for treatment of lymphoma, and newer combinations containing this drug should be further studied.

Ifosfamide-based chemotherapy regimens in treatment of lymphoma: the M.D. Anderson experience. Publishing Authors By Initials

For similar neoplasms: neoplasms by histologic type: lymphoma research abstracts see: neoplasms: neoplasms by histologic type: lymphoma research

PUBMED ID PMID:

MEDLINE DATE:

Ifosfamide-based chemotherapy regimens in treatment of lymphoma: the M.D. Anderson experience. Journal Published:

PUBLICATION TYPE: Review

Journal: European journal of haematology. Supplementum

VOLUME: 64

Page Numbers: 8-13

Journal Abbreviation:

ISSN: 0902-4506

DAY: 26

MONTH: Jul

YEAR: 2001

Ifosfamide-based chemotherapy regimens in treatment of lymphoma: the M.D. Anderson experience. Information

Number of References: 29

LANGUAGE: eng

NlmUniqueID: 8703474

Ifosfamide-based chemotherapy regimens in treatment of lymphoma: the M.D. Anderson experience. Keywords Mesh Terms:

KEYWORDS: Lymphoma

MESH TERMS: therapy

Chemical & Substance for Abstract: Ifosfamide-based chemotherapy regimens in treatment of lymphoma: the M.D. Anderson experience. Information

Substance Name: Ifosfamide

Registry Number: 3778-73-2

Grant and Affiliation Information for Ifosfamide-based chemotherapy regimens in treatment of lymphoma: the M.D. Anderson experience.

AFFILIATION: Department of Lymphoma/Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4095, USA. fhagemei@aol.com

Country: Denmark

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Eur J Haematol Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Ifosfamide-based chemotherapy regimens in treatment of lymphoma: the MD Anderson experience Related Publications

• Abrogation of signal transducer and activator of transcription 3 reactivation after Src kinase inhibition results in synergistic antitumor effects.
• Angiotensin II metabolism and blood pressure in chronic renal disease.
• Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinase.
• Classification of refractive errors.
• Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease.
• Degrasyn activates proteasomal-dependent degradation of c-Myc.
• Diagnosis of myocardial ischemia in man. Concluding remarks: the "stunned" cardiologist.
• Effect of the differential geometric form factor on differential absorption lidar measurements with topographical targets.
• Heredofamilial infantile cerebral degeneration: the relationship of systemic factors to the pathogenicity.
• High-dose ascorbic acid infusion abolishes chronic vasoconstriction and restores resting leg blood flow in healthy older men.
• Histochemical reactions of the secretory cells of the Stannius corpuscles in Palamys sarda L.
• Identification of apoptotic drugs: multiparametric evaluation in cultured hepatocytes.
• Ifosfamide-based chemotherapy regimens in treatment of lymphoma: the M.D. Anderson experience.
• Insulin catabolism in chronic uraemia and in anephric man before and after dialysis treatment.
• Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years.
• Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells.
• Metabolic clearance rate of angiotensin II in arterial hypertension.
• RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth.
• RAGE: A Single Receptor for Several Ligands and Different Cellular Responses: The Case of Certain S100 Proteins.
• Restrained expectations in late pregnancy following loss.
• S100B causes apoptosis in a myoblast cell line in a RAGE-independent manner.
• The Quality of Life Profile--Adolescent Version: background, description, and initial validation.
• The Rb86 single injection method for the study of the coronary circulation in man.
• The kinetics of plasma noradrenaline in normal and hypertensive subjects.
• [Brescia Local Health Autority Population Database: a method based on current data for monitoring chronic diseases and management]
• [Implementation and use of an electronic medical record in a department of cardiology: ten-year experience]
• [Not Available.]
• [The effect of glycine load on porphyrin metabolism in lead poisoning patients]